| Income Statement | 2025-09-28 | 2025-06-29 | 2025-03-30 | 2024-09-29 |
|---|---|---|---|---|
| Revenue | 7,990 | 7,468 | 5,098 | 4,317 |
| Cost of revenue | 6,589 | 5,526 | 4,837 | 4,959 |
| Gross profit (loss) | 1,401 | 1,942 | 261 | -642 |
| Research and development | 28,180 | 28,148 | 25,929 | 24,220 |
| Selling, general and administrative | 20,194 | 17,527 | 16,892 | 20,744 |
| Impairment of equipment | - | - | - | 0 |
| Restructuring cost | 0 | 0 | - | 3,661 |
| Total operating expenses | 48,374 | 45,675 | 42,821 | 48,625 |
| Loss from operations | -46,973 | -43,733 | -42,560 | -49,267 |
| Change in fair value of common stock warrants | -1,867 | 5,885 | -15,796 | -29,899 |
| Gain on bargain purchase of assets | 0 | 4,761 | - | - |
| Interest income | 2,540 | 2,427 | 2,434 | 2,859 |
| Interest expense | 11,765 | 1,705 | 1,716 | 1,718 |
| Other income (loss), net | 140 | -992 | 2,353 | -2,217 |
| Total other income (loss), net | -7,218 | -1,394 | 18,867 | 28,823 |
| Loss before income tax expense (benefit) | -54,191 | -45,127 | -23,693 | -20,444 |
| Income tax expense (benefit) | -422 | -861 | -162 | 2,194 |
| Net loss | -53,769 | -44,266 | -23,531 | -22,638 |
| Net gain (loss) attributable to non-controlling interests | -56 | 262 | -21 | -102 |
| Net loss attributable to enovix | -53,713 | -44,528 | -23,510 | -22,536 |
| Net loss per share attributable to enovix shareholders, basic (in dollars per share) | -0.26 | -0.22 | -0.12 | -0.13 |
| Net loss per share attributable to enovix shareholders, diluted (in dollars per share) | -0.27 | -0.22 | -0.12 | -0.3 |
| Weighted average number of common shares outstanding, basic (in shares) | 206,458,846 | 204,819,119 | 191,304,975 | 176,680,578 |
| Weighted-average shares outstanding used in computing net loss per share of common stock, diluted (in shares) | 206,811,315 | 204,819,119 | 191,304,975 | 176,872,382 |
Enovix Corp (ENVX)
Enovix Corp (ENVX)